Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · IEX Real-Time Price · USD
1.140
+0.060 (5.56%)
May 17, 2024, 4:00 PM EDT - Market closed
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $42.45 million as of May 17, 2024. Its market cap has decreased by -51.70% in one year.
Market Cap
42.45M
Enterprise Value
14.65M
1-Year Change
-51.70%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $42.45M, a decrease of -90.05%. That is a compound annual growth rate of -59.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 42.10M | 5.51% |
May 16, 2024 | 39.90M | -3.39% |
May 15, 2024 | 41.30M | 2.74% |
May 14, 2024 | 40.20M | 4.15% |
May 13, 2024 | 38.60M | -5.16% |
May 10, 2024 | 40.70M | -6.22% |
May 9, 2024 | 43.40M | 4.08% |
May 8, 2024 | 41.70M | -3.92% |
May 7, 2024 | 43.40M | 0.70% |
May 6, 2024 | 43.10M | 5.90% |
May 3, 2024 | 40.70M | 12.43% |
May 2, 2024 | 36.20M | -2.69% |
May 1, 2024 | 37.20M | 3.62% |
Apr 30, 2024 | 35.90M | - |
Apr 29, 2024 | 35.90M | -4.52% |
Apr 26, 2024 | 37.60M | 8.05% |
Apr 25, 2024 | 34.80M | -4.66% |
Apr 24, 2024 | 36.50M | 0.83% |
Apr 23, 2024 | 36.20M | -4.49% |
Apr 22, 2024 | 37.90M | -4.29% |
Apr 19, 2024 | 39.60M | -10.20% |
Apr 18, 2024 | 44.10M | 4.01% |
Apr 17, 2024 | 42.40M | -5.36% |
Apr 16, 2024 | 44.80M | 3.23% |
Apr 15, 2024 | 43.40M | 6.63% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Precision Optics Corporation | 40.35M |
Sensei Biotherapeutics | 40.13M |
VYNE Therapeutics | 40.03M |
Daré Bioscience | 40.00M |
OncoCyte | 39.96M |
Quince Therapeutics | 39.76M |
Cyclo Therapeutics | 39.73M |
Estrella Immunopharma | 39.44M |